Journal article

Long-Term Verification of Functional and Structural Renal Damage After Renal Sympathetic Denervation


Authors listDoerr, Oliver; Liebetrau, Christoph; Moellmann, Helge; Gaede, Luise; Troidl, Christian; Wiebe, Jens; Renker, Matthias; Bauer, Timm; Hamm, Christian; Nef, Holger

Publication year2016

Pages1298-1303

JournalCatheterization & Cardiovascular Interventions

Volume number87

Issue number7

ISSN1522-1946

eISSN1522-726X

DOI Linkhttps://doi.org/10.1002/ccd.26355

PublisherWiley


Abstract
Previous studies of renal sympathetic denervation (RSD) excluded patients with impaired renal function to avoid potential RSD-related renal damage. Measurement of the highly sensitive biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) has shown that RSD does not aggravate renal damage during the early post-procedural period. The aim of the present study was to examine the effect of RSD on blood pressure (BP) reduction and renal function after a long-term follow-up. A total of 62 consecutive patients undergoing RSD were included in this study. Serum NGAL and KIM-1 were collected prior to RSD and at 24 hr, 48 hr, and 3 months after RSD. BP measurements, antihypertensive medication use, and safety events were followed over a three-year period. Follow-up data were available over 36.9[+/- 3.4] months in 47 of 62 (75.8%) of the initially included patients. At this time point a significant systolic BP reduction of 23 mm Hg (P > 0.001) was documented, and there were no significant changes in serum creatinine (P=0.14), blood urea nitrogen (P=0.33), or estimated glomerular filtration rate (eGFR) (P=0.2) values. There were also no significant changes documented in patients with impaired renal function (eGFR < 45 mL/min) during the early post-procedural period or the long-term follow-up (P=0.34). The results of the present study show a sustained effect of RSD on BP reduction after a three-year follow-up, and there was no evidence of renal failure. These results provide verification of the long-term safety and effectiveness of RSD, even in patients with impaired renal function. (C) 2015 Wiley Periodicals, Inc.



Citation Styles

Harvard Citation styleDoerr, O., Liebetrau, C., Moellmann, H., Gaede, L., Troidl, C., Wiebe, J., et al. (2016) Long-Term Verification of Functional and Structural Renal Damage After Renal Sympathetic Denervation, Catheterization & Cardiovascular Interventions, 87(7), pp. 1298-1303. https://doi.org/10.1002/ccd.26355

APA Citation styleDoerr, O., Liebetrau, C., Moellmann, H., Gaede, L., Troidl, C., Wiebe, J., Renker, M., Bauer, T., Hamm, C., & Nef, H. (2016). Long-Term Verification of Functional and Structural Renal Damage After Renal Sympathetic Denervation. Catheterization & Cardiovascular Interventions. 87(7), 1298-1303. https://doi.org/10.1002/ccd.26355



Keywords


ARTERY DENERVATIONGELATINASE-ASSOCIATED LIPOCALINlong-term verificationNERVE ACTIVITYNGALrenal denervationresistant hypertensionRESISTANT HYPERTENSIONURINARY

Last updated on 2025-21-05 at 18:34